ELI LILLY & Co false 0000059478 0000059478 2021-12-15 2021-12-15 0000059478 us-gaap:CommonClassAMember 2021-12-15 2021-12-15 0000059478 lly:A1.000NotesDueJune22022Member 2021-12-15 2021-12-15 0000059478 lly:A718NotesDueJune12025Member 2021-12-15 2021-12-15 0000059478 lly:A1.625NotesDueJune22026Member 2021-12-15 2021-12-15 0000059478 lly:A2.125NotesDueJune32030Member 2021-12-15 2021-12-15 0000059478 lly:A625Notesdue2031Member 2021-12-15 2021-12-15 0000059478 lly:A5000NotesDue2033Member 2021-12-15 2021-12-15 0000059478 lly:A6.77NotesDueJanuary12036Member 2021-12-15 2021-12-15 0000059478 lly:A1625NotesDue2043Member 2021-12-15 2021-12-15 0000059478 lly:A1.700Notesdue2049Member 2021-12-15 2021-12-15 0000059478 lly:A1125NotesDue2051Member 2021-12-15 2021-12-15 0000059478 lly:A1375NotesDue2061Member 2021-12-15 2021-12-15

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 15, 2021

 

 

ELI LILLY AND COMPANY

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Indiana   001-06351   35-0470950
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

 

Lilly Corporate Center
Indianapolis, Indiana
  46285
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (317) 276-2000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock (no par value)    LLY    New York Stock Exchange
1.000% Notes due 2022    LLY22    New York Stock Exchange
7 1/8% Notes due 2025    LLY25    New York Stock Exchange
1.625% Notes due 2026    LLY26    New York Stock Exchange
2.125% Notes due 2030    LLY30    New York Stock Exchange
0.625% Notes due 2031    LLY31    New York Stock Exchange
0.500% Notes due 2033    LLY33    New York Stock Exchange
6.77% Notes due 2036    LLY36    New York Stock Exchange
1.625% Notes due 2043    LLY43    New York Stock Exchange
1.700% Notes due 2049    LLY49A    New York Stock Exchange
1.125% Notes due 2051    LLY51    New York Stock Exchange
1.375% Notes due 2061    LLY61    New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 2.02

Results of Operations and Financial Condition.

On December 15, 2021, Eli Lilly and Company (the “Company”) issued a press release updating its financial guidance for 2021 and announcing its financial guidance for 2022. In addition, on the same day, the Company held a teleconference for analysts and media to discuss this guidance. The teleconference was webcast on the Company’s website. The press release is attached to this Form 8-K as Exhibit 99.1.

The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.


Item 9.01

Financial Statements and Exhibits.

 

(d)

Exhibits

 

Exhibit No.

  

Description

99.1    Press Release dated December 15, 2021
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

ELI LILLY AND COMPANY
(Registrant)
By:  

/s/ Donald A. Zakrowski

Name:   Donald A. Zakrowski
Title:   Vice President, Finance, and Chief Accounting Officer
Date:   December 15, 2021